What are the urinalysis (UA) findings in a male with gonorrhea and/or chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Urinalysis Findings in Males with Gonorrhea and/or Chlamydia

In males with gonorrhea and/or chlamydia, urinalysis typically shows ≥10 white blood cells per high-power field and a positive leukocyte esterase test on first-void urine, indicating urethral inflammation. 1

Key Urinalysis Findings

Leukocyte Esterase and WBCs

  • Positive leukocyte esterase test on first-void urine specimen is a key indicator 1
  • Microscopic examination of first-void urine sediment showing ≥10 WBC per high-power field 1
  • These findings document urethritis, which is the hallmark of these infections in males

Diagnostic Performance

  • Leukocyte esterase testing has shown sensitivity of 66.7-100% and specificity of 80-91% for detecting gonorrhea or chlamydia in asymptomatic males 2, 3, 4
  • The positive predictive value ranges from 42-67.5%, while negative predictive value is higher at 92.8-94% 5, 4

Distinguishing Features

Gonorrhea

  • In symptomatic males, Gram stain of urethral discharge showing polymorphonuclear leukocytes with intracellular Gram-negative diplococci is diagnostic for gonorrhea (sensitivity >95%, specificity >99%) 1
  • However, Gram stain has lower sensitivity in asymptomatic men and is not recommended for ruling out infection 1

Chlamydia

  • No specific urinalysis findings distinguish chlamydial from gonococcal urethritis
  • Both infections present with similar urinalysis findings of pyuria and positive leukocyte esterase

Clinical Application

When to Test

  • First-void urine (first 10-30 mL of urine) should be collected for optimal results 6
  • Nucleic acid amplification tests (NAATs) on urine specimens are preferred for definitive diagnosis with sensitivity >95% and specificity >99% 6

Limitations

  • Urinalysis alone cannot definitively diagnose the specific pathogen
  • Approximately 10% of males with urethritis may have negative urinalysis findings despite infection 1
  • In asymptomatic males, leukocyte esterase testing performs better in younger populations (≤35 years) 4

Important Considerations

  • Co-infection with both gonorrhea and chlamydia is common, occurring in up to 40% of cases 7
  • Treatment should target both pathogens even when only one is detected 7
  • Urinalysis findings may persist for 1-2 weeks after effective treatment
  • False positives can occur with other genitourinary conditions (urinary tract infections, prostatitis)

Pitfalls to Avoid

  • Do not rely solely on urinalysis for definitive diagnosis; confirmation with NAATs is essential
  • Do not rule out infection based on negative urinalysis in asymptomatic males (sensitivity limitations)
  • Do not forget to screen for other STIs, including HIV and syphilis, in patients with positive findings
  • Do not assume treatment failure if urinalysis remains abnormal shortly after treatment completion

In summary, while urinalysis findings of pyuria and positive leukocyte esterase strongly suggest urethritis from gonorrhea and/or chlamydia in males, definitive diagnosis requires pathogen-specific testing with NAATs, which should be performed on first-void urine specimens.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Urinary leukocyte esterase screening for asymptomatic sexually transmitted disease in adolescent males.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 1991

Guideline

Gonorrhea Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Need for treatment of gonorrhea to be effective against Chlamydia trachomatis.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.